Board of Sun Pharma Advanced Research Company Ltd has appointed Mr. Anil Raghavan, as a Chief Executive Officer (CEO) and whole time key managerial personnel of the Company with immediate effect, for a term of five years i.e upto 24th May 2026, subject to approval of members in a General Meeting of the Company.
Anil also serves as the Chairman of an early stage Machine Learning company, AIRA Matrix which focuses on the application of high content image processing and deep learning to transform drug development and clinical practice.
Prior to joining SPARC, he served as the Managing Director of the India and Sri Lanka business of Quintiles, a global pharmaceutical services company. He was part of Quintiles leadership team and an active member of its Asia management board. Anil spent a decade consulting with leading firms such as Arthur Andersen, KPMG and Cambridge Technology Partners before joining Quintiles.
